CytoSorbents Corporation (CTSO) Reports $43K Operating Cash Flow in Q3

CytoSorbents generated approximately $43K in positive Q3 operating cash flow, excluding $251K in restructuring-related payments, versus approximately $200K of cash burn in Q2 2026 and $2.7M in Q3 2025 on the same basis. Adjusted EBITDA loss narrowed 86% to approximately $0.3M.Material DetailsContex…